PCR PCC Rokita SA
PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy, and Other Activities. The Polyurethanes segment produces polyols, polyurethane systems, and prepolymers; and flexible foams, rigid foams, coatings, elastomers, adhesives, impregnations, and other products. The Chlorine Derivatives segment provides chlorine, sodium hydroxide, caustic soda, chlorobenzene, and hydrochloric acid. The Other Chemical Activities segment offers phosphorus-derivative and naphthalene-derivative products. The Energy segment produces and distributes electricity, thermal energy, demineralized water, and compressed air. The Other Operations segment is involved in the provision of maintenance services for technological equipment and installations; industrial waste management; hazardous goods transport services; management and administration services; environmental protection; asset management and security; construction and repairs of steel industrial equipment; and trades in chemical products, and other. It also provides transport and freight, and maintenance services; research of chemical substances; and designs, constructs, and assembles, as well as repairs industrial equipment, tanks, pipelines, and welded structure. The company sells its products under the Crossin, Ekoprodur, ROKOPOL, and ROKESTER brands. PCC Rokita SA was incorporated in 2002 and is headquartered in Brzeg Dolny, Poland. PCC Rokita SA is a subsidiary of PCC SE.…
Industry Peers
ChemicalsKey Statistics
About PCC Rokita (WSE: PCR)
›
PCC Rokita (WSE: PCR) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Chemicals industry, part of the Basic Materials sector, and reports about 1,600 employees.
The shares were at 61.60 PLN on 19 November 2026, down 7.1% over 52 weeks. Its 52-week range is 58.40 PLN to 74.40 PLN: the price is 17.2% below the high and 5.5% above the low.
At a market capitalisation of 1.25B PLN, it trades at 11.0 times trailing earnings and 8.3 times forward earnings. The median trailing P/E of its 15 largest Chemicals peers is 14.4, a discount of 23% for PCR. It pays a dividend yielding 4.25% (it pays out 47% of its earnings), against a median of 4.10% among the dividend payers in that peer group.
PCC Rokita reports return on equity of 4.5%, an operating margin of 8.8% and revenue up 13.5% year over year.
Its debt exceeds its cash by 347.31M PLN, a debt-to-equity ratio of 0.40. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 78.27 PLN is 27.1% above the current price.